Sign up Australia
Proactive Investors - Run By Investors For Investors

MMJ PhytoTech has shares halted pending medical cannabis update from Canada

The halt will remain in place until Tuesday 17th October 2017.
MMJ PhytoTech has shares halted pending medical cannabis update from Canada
The company's shares are in pre-open

The company’s subsidiary, Harvest One Cannabis Inc, is preparing details regarding the status of its application for a sales amendment to its cultivation license granted under Canada’s Access to Cannabis for Medical Purposes Regulations.

MMJ is focused on becoming a large-scale cannabis producer, targeting direct supply to the growing Canadian medical and recreational markets which will have an estimated combined value of C$8-9 billion by 2024.

The halt will remain in place until the opening of trade on Tuesday 17th October 2017, or earlier if an announcement is made to the market.





Register here to be notified of future MMJ Company articles
View full MMJ profile View Profile

MMJ PhytoTech Ltd Timeline

Related Articles

The Hydroponics Company Ltd issued a cannabis research licence
July 11 2017
The licence allows Canndeo to build its exclusive Plant Breeders Rights.
Clinical Trial
August 04 2017
The study, codenamed INTEREST, should be wrapped up in the fourth-quarter
cancer cells
July 12 2017
The US-based, London-listed healthcare group topped expectations with its latest results and analysts are tipping it for more success this year

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use